Mayo Clinic researchers have developed a proactive treatment protocol for alcohol use disorder that eliminated heavy alcohol relapse in liver-transplant patients [1].
This development is critical because alcohol relapse can lead to organ failure and death in transplant recipients. By addressing addiction proactively, clinicians may significantly increase the long-term survival rates of patients receiving new livers.
Dr. Channa Jayasekera and a team of researchers at the Mayo Clinic led the study [1]. The team implemented a specific protocol designed to manage alcohol use disorder following the transplant procedure. The heavy alcohol relapse rate among patients who followed this proactive protocol was 0%, the researchers said [1].
This result stands in sharp contrast to previous medical outcomes. The historical heavy alcohol relapse rate for patients after a liver transplant is approximately 25% [1]. The disparity suggests that a structured, proactive approach to addiction can overcome the high risk of relapse typically associated with these surgeries.
The urgency of such medical advancements is often highlighted by the loss of patients to the disease. In a separate account of the struggle with addiction, a parent of a deceased patient told the Detroit News that their son died at 38 years old in December 2025 with end-stage alcohol-related liver disease.
Researchers focused on reducing relapse to improve overall post-transplant outcomes [1]. The protocol emphasizes early and consistent intervention rather than reacting to a relapse after it has already occurred. This shift in strategy aims to protect the transplanted organ, and the life of the patient.
“The heavy alcohol relapse rate among patients who followed this proactive protocol was 0%.”
The elimination of heavy relapse in this cohort suggests that alcohol use disorder can be managed as a treatable medical condition rather than an inevitable risk factor. If this protocol is adopted widely, it could expand the number of candidates eligible for liver transplants by reducing the perceived risk of post-operative failure.
